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The negative symptoms of schizophrenia, avolition, alogia, apathy and impaired or nonexistent social functioning,
are strongly correlated with the progressive course and long-term prognosis of the disease, undermining the
patient’s ability to integrate socially, interpersonal skills and quality of life. At a time when new drug strategies are
being developed, a better understanding of the etiology and pathogenesis underpinning the occurrence of
negative symptoms constitutes an essential prerequisite for real therapeutic advances. Approaching this vulnerability
from the neurodevelopmental perspective is especially pertinent with regard to the experimental studies conducted
in animals. Several models have been put forward, involving a variety of topics such as the deleterious impact of a
prenatal infection or of early maternal deprivation on brain development, or else the consequences of trauma and
abuse suffered during childhood. These various models are based on biological abnormalities that could guide the
identification of new therapeutic targets. They notably include the hyperreactivity of the hypothalamic-pituitary-
adrenal axis and dysfunction of corticostriatal glutamatergic transmission. As such, in the traumagenic model, which
associates neurodevelopmental and neurodegenerative processes, the dysfunction of corticostriatal glutamatergic
transmission, by reducing the tonic dopamine release, could be the cause of an increase in the phasic dopamine
release linked to stress. This excessive phasic response to stress may induce cerebral damage by increasing
excitotoxicity and oxidative stress.
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The complexity and clinical heterogeneity of schizophre-
nia raise questions about the respective roles of the vari-
ous vulnerability factors involved. Among these factors,
those related to the environment, whether of a psycho-
social or biological nature, whether occurring early or
later, remain non-specific factors that may play a role in
the etiology and course of the disorder.
The neurodevelopmental hypothesis is founded on evi-
dence from clinical, experimental and brain imaging
findings. This model is based on the occurrence of early
abnormalities in neurodevelopmental processes, well inCorrespondence: frederic.limosin@ccl.aphp.fr
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unless otherwise stated.advance of the onset of the disorder. The main neurode-
velopmental hypotheses implicate structural abnormal-
ities involving the migration of neurons and laminar
differentiation of the cortex, occurring during the sec-
ond trimester of pregnancy. However, all stages of nor-
mal brain development may be involved, from the
proliferation of stem cells to the differentiation and mi-
gration processes, and then from dendritic and axonal
growth to the myelination process, a process that con-
tinues at least until early adulthood, notably in the pre-
frontal cortex.Review
Epidemiological studies of separation/adoption, of half-
siblings and twins show that the familial clustering of
cases of schizophrenia is not solely the result of gen-
etic factors, but also of environmental factors. Twin stud-
ies estimate heritability at approximately 80% [1], whileThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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families, determined that the genetic factors accounted for
64% of the vulnerability to develop schizophrenia, com-
pared to 36% for environmental factors [2]. Even if the
respective influence of these two types of vulnerability fac-
tors varies according to the disease subtype (hence the
importance of distinguishing disease phenotypes), their
interaction appears to be fundamental to the etiology and
course of the disorder. In addition, the notion of vulner-
ability and the role of environmental factors are complex
notions in more than one respect:
1. Firstly, the influence of environmental factors can be
exerted on the occurrence of the disorder, by
contributing to the underlying etiology, as well as on
its progressive course, whether this be in terms of
clinical characteristics (severity, age of onset,
comorbidities, etc.), or in terms of the response to
drug treatments.
2. Secondly, the notion of environment encompasses
highly varied factors, both by their nature
(demographic, climate, dietary, psychological, etc.)
and by the stage of development at which they
intervene. As such, ‘early’ environmental factors,
whose influence is exerted well in advance of the
onset of the disease, such as pre-and peri-natal
factors, are distinguished from ‘late’ factors, such
as, for example, the role of stressful life events in
the progressive course of the disorder. Ultimately,
the environment is understood in a very broad,
and thus heterogeneous sense, ranging from the
internal biological environment to the external
context.
3. Lastly, we can no longer consider environmental
factors in isolation but rather must consider them
within integrated vulnerability models. In addition,
more so than causal risk factors, vulnerability factors
are considered to be predisposing disease factors or
intermediate factors whose influence alone would be
insufficient to trigger the onset of the disorder. In
these models, the interactions between
environmental factors and genetic factors appear to
be especially relevant.
Environmental factors most often implicated
Psychosocial factors
 The consequences of immigration have given rise to
several epidemiological studies, notably in England
and the Netherlands, which found an increased risk
of developing schizophrenia in immigrants, whether
of the first or second generation [3]. This risk could
be partly due to conditions of greater social
adversity, but other hypotheses have been putforward, such as the mother’s diminished immunity
to the viruses of the host country.
 The psychological effect of an urban environment
may also interact with levels of reality distortion and
depressive symptoms in people experiencing
first-episode psychosis and may affect the syndromal
presentation of psychotic disorders [4]. For
individuals suffering from psychosis, spending time
in an urban environment makes them think more
negatively about other people and increases their
paranoia [5].
 The role of disturbances in early parent/child
relationships, whether it be early separation, a lack
of emotional support and physical contact, or abuse,
has also been invoked in the later development of
the disorder. Zugno et al. showed that rats subjected
to maternal deprivation had an increased risk for
schizophrenia-like behavior and cholinergic
alteration [6].
Biological factors
 Toxicity factors, foremost among them, psychoactive
substances like cannabis, amphetamines or cocaine,
can cause acute episodes punctuating the course of
the disorder. In most cases, the toxic agents
involved determine to a lesser extent the onset of a
chronic disease than they precipitate its onset or
interfere with its progressive course, making it worse
with more complications and sometimes poorer
treatment response [7]. Nonetheless several
prospective cohort studies on the general population
have shown that subjects who use cannabis had a
higher risk of developing a psychotic disorder [8].
 Role of certain infectious agents: It was during the
nineteenth century that the hypothesis of the role of
infectious agents in the occurrence of schizophrenia,
as well as in bipolar disorder, was first formulated,
notably by Jean Esquirol in 1845, followed by Eugen
Bleuler in 1911 and Emil Kraepelin in 1919 [9]. This
hypothesis was in line with the discovery of the
infectious nature of the psychiatric manifestations of
syphilis which occurred during the eighteenth
century. Among the different infectious agents, the
influenza virus has been implicated most often. Its
pathogenic role was suggested for the first time
during the 1918 pandemic: many individuals who
contracted the “Spanish” flu developed psychiatric
disorders, especially with clinical presentations that
resembled schizophrenia, as described at the time by
Menninger [10].
However, the epidemiological starting point for the hy-
potheses formulated on the role of early environmental
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imbalance in the distribution of births of future patients,
which is evident in schizophrenia. Many studies have
identified, in the Northern Hemisphere, an excess of
births of subjects with schizophrenia during the winter
and early spring, especially between December and April
[11]. On average, it is estimated that in European and
North American countries, the proportion of subjects
with schizophrenia born in winter or at the start of
spring exceeds the figures expected in the general popu-
lation by about 5 to 15%. The “age-incidence” effect, which
concerns all diseases where the incidence increases with
the age of subjects, seems too small to account for the
observed seasonal peak of births. In addition, the exist-
ence of this peak during the austral winter in the Southern
Hemisphere, even though it is less evident, runs counter
to such a bias [12]. This phenomenon of seasonal imbal-
ance is not specific to schizophrenia, since it is found in
other diseases like bipolar disorder [13] or substance or al-
cohol abuse [14].
In order to account for the observed seasonal distribu-
tion of births, various hypotheses have been put forward,
some of which are more satisfactory than others: cli-
mate, dietary, obstetrical, chronobiological or infectious.
Among these alternatives, two quickly gained traction:
the role of obstetrical complications and the infectious
hypothesis, falling in line with a neurodevelopmental
model of schizophrenia.
 Role of obstetrical complications: obstetrical
complications are associated with an increased risk
of developing schizophrenia. It is a well-documented
yet low risk with an odds ratios adjusted for the effect
of exposure being approximately 2. The complications
most often involved are bleeding during pregnancy,
pre-eclampsia and gestational diabetes, as well as
certain delivery complications, such as uterine atony,
neonatal asphyxia and hemorrhage [15]. Once again,
this association is not specific to schizophrenia, as a
higher frequency of obstetrical complications has been
found in other psychiatric disorders, such as mood
disorders, anorexia nervosa or autism [16,17].
 Role of the influenza virus: influenza infection during
the gestation period is associated with an increased
risk for the child of later developing schizophrenia
[18]. Once again, this association is not specific to
this diagnosis, as it is found, for example, in the
predisposition to unipolar mood disorder [19]. The
mechanism of action of the influenza virus has not
been elucidated, but the leading hypothesis suggests
that in certain genetically predisposed mothers,
antiviral maternal antibodies could cause an
autoimmune reaction which is harmful to the fetal
brain [20].The neurodevelopmental hypothesis applied to
negative symptoms
The negative symptoms of schizophrenia include avoli-
tion, alogia, apathy and impaired or nonexistent social
functioning. The negative symptoms are so called be-
cause they are an absence as much as a presence: inex-
pressive faces, monotone and monosyllabic speech, few
gestures, seeming lack of interest in the world and other
people, inability to feel pleasure or act spontaneously.
Origin of the definition of the negative symptoms can be
found in the work of John Hughlings Jackson [21]. From
1874 to 1876, Hughlings Jackson adapted Herbert Spencer's
evolutionary theory to neurological disease and addressed
the relationship between the centres in his hierarchy. Fol-
lowing Spencer, Hughlings Jackson concluded that the
highest nervous centres evolved out of the lower. Patients
with diseases of the highest centres develop two types of
symptoms, negative symptoms due to the loss of higher
centres and positive symptoms due to the emergence of
lower centres. Positive symptoms are simpler and less dif-
ferentiated than the negative symptoms which they re-
place [21]. Furthermore, recent data suggest that negative
symptoms should not be considered only as a unitary con-
struct, and that measurement of these symptoms should
distinctly assess motivation, pleasure, and emotion expres-
sion factors [22]. Moreover, particular attention should be
paid to the distinction between primary versus secondary
negative symptoms and between prominent and predom-
inant negative symptom profiles [23].
The frequency of the deficit syndrome varies depend-
ing on the progressive stage of the disease, from about
15% for the first episodes up to 25-30% for the later
phases [24]. The wider use of second-generation antipsy-
chotics may have permitted an appreciable reduction in
the prevalence of negative symptoms; at least, this is what
the recent study by Shivashankar et al. [25] suggests, find-
ing such a reduction over a period of 25 years (between
1981 and 2006). The fact nevertheless remains that nega-
tive symptoms comprise a major factor in interpersonal
and social isolation and impairment of quality of life. Yet,
even if negative symptoms are associated with greater
genetic determinism than positive symptoms [26-29], the
analysis of the neurodevelopmental factors likely to be in-
volved in their occurrence appears to be relevant in more
than one respect, especially from the perspective of identi-
fying new therapeutic targets.
Data from epidemiological studies
Several studies have demonstrated an association between
prenatal infection and certain functions and morpho-
logical brain abnormalities in patients with schizophrenia,
whether they be in executive function deficits or an
enlarged cavum septum pellucidum, suggestive of dys-
genesis [30,31].
Limosin BMC Psychiatry 2014, 14:88 Page 4 of 6
http://www.biomedcentral.com/1471-244X/14/88Some studies have found an association between the
peak of birth seasonality and certain clinical forms, mainly
disorganized subtype [32], paranoid subtype [33] or with
pronounced negative symptomatology [34]. In addition,
patients with schizophrenia who were exposed to an ele-
vated risk of influenza infection during pregnancy are
more likely to be single, which could indicate poorer
social adjustment [35], and with the disorganized clin-
ical subtype [18].
Experimental studies conducted in animals
 Prenatal infection model
One of the experimental models used to analyze the
impact of a prenatal infection consists of injecting
the pregnant female rodent with polyriboinosinic-
polyribocytidylic acid (Poly I:C), a synthetic analog
of double-stranded RNA that stimulates an immune
response with cytokine secretion. It has been shown
that this exposure is the cause of cognitive, behavioral
and pharmacological dysfunction in the neonate as
an adult, and that these abnormalities result in
disorders found in schizophrenia, such as disorders of
sensorimotor gating, selective attention, working
memory or hypersensitivity to psychostimulants.
In addition, the timing of this exposure appears to
be paramount, since the abnormalities induced will
vary, depending on the stage of pregnancy. Thus, if
exposure is late, at the end of gestation, one
observes as an adult rodent persistent behavioral
abnormalities with learning disabilities [36],
disturbance of visual-spatial working memory [37]
and hypersensitivity to the glutamatergic NMDA
(N-methyl-D-aspartate) receptor blockade during
treatment with the antagonist dizocilpine (MK-801)
[37]. They thus involve precisely the dysfunctions
that may underpin the negative symptoms found in
schizophrenia.
Bitanihirwe et al. [38] injected mice with Poly I:C on
gestation day 17, hence during the late gestational
phase. In those neonates grown as adults, deficits in
social interaction, anhedonic behavior, and
alterations in locomotor behavioral response to
acute administration of apomorphine were
demonstrated. In addition, male subjects were found
to lack cognitive and behavioral flexibility. Lastly,
the authors found reduced levels of dopamine and
glutamate in the prefrontal cortex (PFC) and
hippocampus, as well as decreased levels of
γ-aminobutyric acid (GABA) in the hippocampus
and of glycine in the PFC. These abnormalities are
in favor of a neurodevelopmental model that could
account for the occurrence of negative symptoms,
with, in addition, an effect correlated with gender. Experience of maternal deprivation
In the neonate rat, long periods of maternal
deprivation (from 3 to 24 hours versus 3 to
15 minutes) are associated with hyperactivity of the
HPA (hypothalamic-pituitary-adrenal) axis [39,40],
and with a prepulse inhibition (PPI) deficit or lack of
reduction in the intensity of startle [41]. The term
PPI describes the inhibition of the startle reflex
triggered by a violent and unexpected exteroceptive
stimulus (pulse) when it is preceded in the short
term by a weaker prestimulus (prepulse), too weak
to itself induce the reflex. PPI is thus an operational
measure of sensorimotor gating, reflecting the
capacities of the individual to regulate, to “buffer” the
input of different levels of significance and variable
chaotic flow of sensory information. Maternal
deprivation is also accompanied by cognitive disorders
with impaired learning abilities [42,43].
Moreover, there is a period of brain development
particularly sensitive to the deleterious effects of
maternal deprivation: the stress hyporesponsive
period, which falls, for the rat, between the 4th and
14th postnatal day. Takase et al. [44] thus showed
that among rats subjected to maternal deprivation
during this critical period, only the postpubertal
males had abnormal hippocampal calcineurin
expression associated with a deficit in social
interactions and objective memory. Once again, this
is an animal model linking negative symptoms and
neurodevelopmental impairment.
The traumagenic neurodevelopmental model
This model was proposed in light of two observations:
that of the high prevalence of childhood abuse in patients
with schizophrenia [45], and that of the similarities be-
tween the effects on brain development of the trauma
from abuse and certain biological abnormalities found in
patients with schizophrenia, whether it be hyperreactivity
of the HPA axis or morphological changes to the brain
(cerebral atrophy, ventricular enlargement, reversed cere-
bral asymmetry, hippocampal lesions).
Ross et al. [46] showed that a history of abuse was
negatively correlated with negative symptoms. However,
there may be two distinct patterns of response to stress:
 Some subjects repeatedly confronted with abuse
react through dissociative and positive symptoms: it
then involves not so much a process of cerebral
atrophy, as dysfunction mediated by dopamine,
whence a better response to antidopaminergics [47].
 Other subjects react through hypervigilance
(anxiety, hypersensitivity) that may accentuate the
phenomenon known as “pruning”, normally
occurring at adolescence and corresponding to a
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neuropil) and to neuronal loss. This excessive
neuronal loss could be at the root of the progression
toward negative symptoms in adulthood [48,49].
In this latter model, which associates neurodevelop-
mental and neurodegenerative processes, the glutamate
hypothesis could also play a role. In fact, dysfunction of
corticostriatal glutamatergic transmission, by reducing the
tonic dopamine release, could be the cause of an increase
in the phasic dopamine release linked to stress. This exces-
sive phasic response to stress may induce cerebral damage
by increasing excitotoxicity and oxidative stress.
Lastly, still in this mixed model associating a neurode-
velopmental approach and a neurodegenerative process,
some immune dysfunction could be involved, mainly im-
plicating the role of pro-inflammatory cytokines [50].
Conclusion
The negative symptoms of schizophrenia are a major
factor in interpersonal and social isolation and the im-
pairment of quality of life, and thus represent a major
issue in the field of development of new therapeutic
strategies, notably drug strategies. As such, a better un-
derstanding of the pathogenic mechanisms that under-
pin the occurrence of negative symptoms is an essential
prerequisite for the identification of therapeutic targets.
In this perspective, the neurodevelopmental approach
appears particularly relevant, especially with regard to
experimental animal studies, which have made it pos-
sible to demonstrate a number of biological abnormal-
ities. These notably include hyperreactivity of the HPA
axis and dysfunction of corticostriatal glutamatergic trans-
mission. Additionally, given the modest impact of drug
treatments for negative symptoms to date [51], psycho-
logical factors associated with the development of these
symptoms are of considerable importance and may be vi-
able treatment targets [52].
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